Macleods Pharmaceuticals Ltd — Azithromycin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Azithromycin · $4.5M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #10 Indian exporter of Azithromycin with $4.5M in export value and 91 verified shipments. Macleods Pharmaceuticals Ltd holds a 2.5% market share in Azithromycin exports across 14 countries.
Macleods Pharmaceuticals Ltd — Azithromycin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Azithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $3.3M | 75 | 77.3% |
| KAZAKISTAN | $300.0K | 6 | 7.0% |
| UKRAINE | $100.6K | 3 | 2.4% |
| KAZAKHSTAN | $100.0K | 2 | 2.3% |
| IRAQ | $82.3K | 2 | 1.9% |
| MOZAMBIQUE | $62.1K | 6 | 1.5% |
| ZAMBIA | $51.2K | 9 | 1.2% |
| KENYA | $50.4K | 19 | 1.2% |
| POLAND | $50.0K | 1 | 1.2% |
| GUYANA | $26.3K | 3 | 0.6% |
Macleods Pharmaceuticals Ltd exports Azithromycin to 23 countries. The largest destination is FRANCE accounting for 77.3% of Macleods Pharmaceuticals Ltd's Azithromycin shipments, followed by KAZAKISTAN (7.0%) and UKRAINE (2.4%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azithromycin from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANETPHARMA | FRANCE | $3.0M | 67 |
| BRANCH COMPANY MACLEODS PHARMACEUTI | KAZAKISTAN | $300.0K | 6 |
| PLANETPHARMA ZAC DU GRAND LAUNAY | FRANCE | $223.0K | 5 |
| MACLEODS PHARMACEUTICAL LIMITED LLC | UKRAINE | $100.6K | 3 |
| PLANETPHARMA E GRAND | FRANCE | $100.0K | 2 |
| BRANCH COMPANY MACLEODS | KAZAKHSTAN | $100.0K | 2 |
| ROZ LOJISTIK ULUSLARARASI TASIMACIL | IRAQ | $82.3K | 2 |
| MEDIS FARMACEUTICA LDA | MOZAMBIQUE | $62.1K | 6 |
| MACLEODS PHARMACEUTICAL LIMITED LL | POLAND | $50.0K | 1 |
| YASH PHARMACEUTICALS LTD | ZAMBIA | $38.9K | 8 |
Macleods Pharmaceuticals Ltd supplies Azithromycin to 33 buyers globally. The largest buyer is PLANETPHARMA (FRANCE), followed by BRANCH COMPANY MACLEODS PHARMACEUTI (KAZAKISTAN) and PLANETPHARMA ZAC DU GRAND LAUNAY (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azithromycin Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $74.0M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. Macleods Pharmaceuticals Ltd contributes $4.5M to this total, accounting for 2.5% of India's Azithromycin exports. Macleods Pharmaceuticals Ltd ships Azithromycin to 23 countries through 33 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Azithromycin Exports?
Macleods Pharmaceuticals Ltd's average Azithromycin shipment value is $50.0K per consignment, based on 91 shipments totaling $4.5M. The largest destination is FRANCE (77.3% of Macleods Pharmaceuticals Ltd's Azithromycin exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Azithromycin Exporters?
Macleods Pharmaceuticals Ltd ranks #10 among 853 Indian Azithromycin exporters with a 2.5% market share. The top 3 exporters are LUPIN LIMITED ($11.0M), ALEMBIC PHARMACEUTICALS LIMITED ($8.7M), CIPLA LIMITED ($8.4M). Macleods Pharmaceuticals Ltd processed 91 shipments to 14 destination countries.
What Azithromycin Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZICURE 500MG CPR B/3 (AZITHROMYCIN TAB | $550.0K | 11 |
| AZICURE 200MG/5ML SUSP ORAL F/15ML(AZITHROMYCIN SUSPENSION 200MG/5ML) 1X1 | $395.9K | 8 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES ZITHROX 500 (AZITHROMYCIN TABLETS IP 500 MG) | $300.0K | 6 |
| AZICURE 500MG CPR B/3 (AZITHROMYCIN TABLETS 500MG) AZIC101 1X3S (65570 PAC)TBS | $150.0K | 3 |
| AZICURE 500 (AZITHROMYCIN 500MG TABLETS) 1X3'S (65655 PAC) | $150.0K | 3 |
| AZICURE 200MG/5ML SUSP ORAL F/15ML(AZITHROMYCIN SUSPENSION 200MG/5ML) AZIC102 1X15 ML | $139.0K | 3 |
| AZICURE 250MG CPR B/6 (AZITHROMYCINE TA | $124.4K | 4 |
| AZICURE 200MG/5ML SUSP ORAL F/15ML(AZITHROMYCIN SUSPENSION 200MG/5ML) AZIC102 1X15 MLNOS | $120.6K | 3 |
| AZICURE 500MG CPR B/3 (AZITHROMYCIN TABLETS 500MG) AZIC101 1X3'S (32825 PAC)TBS | $117.4K | 3 |
| AZICURE 500MG CPR B/3 (AZITHROMYCIN TABLETS 500MG) AZIC101 1X3'S (32526 PAC)TBS | $116.6K | 3 |
Macleods Pharmaceuticals Ltd exports 127 distinct Azithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZICURE 500MG CPR B/3 (AZITHROMYCIN TAB with 11 shipments worth $550.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Azithromycin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MICRO LABS LIMITED | $5.5M | 110 | 17 | $50.0K |
| 1 | LINCOLN PHARMACEUTICALS LTD | $4.8M | 97 | 16 | $50.0K |
| 10 | MACLEODS PHARMACEUTICALS LTD ★ | $4.5M | 91 | 14 | $50.0K |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $2.9M | 57 | 10 | $50.0K |
| 11 | EUGIA PHARMA SPECIALITIES LIMITED | $2.8M | 56 | 2 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #10 among 853 Indian Azithromycin exporters. Average shipment value of $50.0K compared to the market average of $86.8K. The closest competitors by value are MICRO LABS LIMITED and LINCOLN PHARMACEUTICALS LTD.
Which Indian Ports Ship Azithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,394 | 16.0% |
| SAHAR AIR | 2,211 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 1,693 | 11.3% |
| DELHI AIR | 1,106 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 902 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 870 | 5.8% |
| Bombay Air | 618 | 4.1% |
| JNPT | 408 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 186 individual customs records matching Macleods Pharmaceuticals Ltd exporting Azithromycin, covering 127 formulations to 23 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Azithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Azithromycin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current shipment-level data, contact TransData Nexus.